(FPE) Fuchs Petrolub SE - Overview
Stock: Lubricants, Greases, Metalworking, Fluids, Coatings
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.47% |
| Yield on Cost 5y | 3.62% |
| Yield CAGR 5y | 4.31% |
| Payout Consistency | 97.7% |
| Payout Ratio | 65.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 22.7% |
| Relative Tail Risk | -8.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.34 |
| Alpha | -13.01 |
| Character TTM | |
|---|---|
| Beta | 0.269 |
| Beta Downside | 0.382 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.21% |
| CAGR/Max DD | 0.11 |
Description: FPE Fuchs Petrolub SE January 08, 2026
Fuchs SE (formerly Fuchs Petrolub SE) designs, manufactures, and distributes a broad portfolio of lubricants and functional fluids across all major regions-including Europe, the Middle East, Africa, Asia-Pacific, and the Americas-serving automotive, industrial, aerospace, wind-energy, and food-processing customers.
The product suite spans automotive and industrial oils (biodegradable, hydraulic, engine, gear, compressor, refrigeration), greases (food-grade, biodegradable, high-temperature, wheel-bearing), metal-processing fluids (cutting, forming, quenching), and specialty applications such as concrete release agents and solid film lubricants, complemented by open-gear and surface-coating services.
Founded in 1931 and headquartered in Mannheim, Germany, the company rebranded from Fuchs Petrolub SE to Fuchs SE in July 2023, reflecting a broader strategic focus beyond traditional petroleum-based products.
Key recent metrics: FY 2023 revenue of roughly €2.2 billion, EBITDA margin around 13 %, and a 5 % YoY increase in automotive lubricant sales driven by higher demand for low-viscosity and synthetic blends. The global lubricants market, valued at ~€150 billion, is projected to grow ~3 % CAGR, with EU environmental regulations boosting demand for biodegradable and low-emission formulations-an area where Fuchs holds a competitive edge.
For a deeper quantitative view, check the ValueRay dashboard for FPE’s latest valuation metrics and scenario analysis.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 295.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -0.32 > 1.0 |
| NWC/Revenue: 20.79% < 20% (prev 18.81%; Δ 1.98% < -1%) |
| CFO/TA 0.14 > 3% & CFO 382.0m > Net Income 295.0m |
| Net Debt (-142.0m) to EBITDA (530.0m): -0.27 < 3 |
| Current Ratio: 2.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (131.0m) vs 12m ago -0.23% < -2% |
| Gross Margin: 34.67% > 18% (prev 0.34%; Δ 3433 % > 0.5%) |
| Asset Turnover: 136.0% > 50% (prev 135.4%; Δ 0.59% > 0%) |
| Interest Coverage Ratio: 71.67 > 6 (EBITDA TTM 530.0m / Interest Expense TTM 6.00m) |
Altman Z'' 3.73
| A: 0.28 (Total Current Assets 1.36b - Total Current Liabilities 621.0m) / Total Assets 2.64b |
| B: 0.09 (Retained Earnings 228.0m / Total Assets 2.64b) |
| C: 0.16 (EBIT TTM 430.0m / Avg Total Assets 2.62b) |
| D: 0.48 (Book Value of Equity 359.0m / Total Liabilities 747.0m) |
| Altman-Z'' Score: 3.73 = AA |
Beneish M -2.96
| DSRI: 1.09 (Receivables 633.0m/573.0m, Revenue 3.56b/3.51b) |
| GMI: 0.99 (GM 34.67% / 34.34%) |
| AQI: 1.04 (AQ_t 0.20 / AQ_t-1 0.19) |
| SGI: 1.01 (Revenue 3.56b / 3.51b) |
| TATA: -0.03 (NI 295.0m - CFO 382.0m) / TA 2.64b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of FPE shares?
Over the past week, the price has changed by +1.34%, over one month by +0.50%, over three months by -0.49% and over the past year by -5.81%.
Is FPE a buy, sell or hold?
What are the forecasts/targets for the FPE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 42 | 39.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 31.5 | 4.4% |
FPE Fundamental Data Overview February 03, 2026
P/E Trailing = 13.7054
P/E Forward = 15.5039
P/S = 1.3224
P/B = 2.0865
Revenue TTM = 3.56b EUR
EBIT TTM = 430.0m EUR
EBITDA TTM = 530.0m EUR
Long Term Debt = 10.0m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 63.0m EUR (from shortTermDebt, last quarter)
Debt = 112.0m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -142.0m EUR (from netDebt column, last quarter)
Enterprise Value = 4.68b EUR (4.71b + Debt 112.0m - CCE 142.0m)
Interest Coverage Ratio = 71.67 (Ebit TTM 430.0m / Interest Expense TTM 6.00m)
EV/FCF = 14.34x (Enterprise Value 4.68b / FCF TTM 326.0m)
FCF Yield = 6.97% (FCF TTM 326.0m / Enterprise Value 4.68b)
FCF Margin = 9.16% (FCF TTM 326.0m / Revenue TTM 3.56b)
Net Margin = 8.29% (Net Income TTM 295.0m / Revenue TTM 3.56b)
Gross Margin = 34.67% ((Revenue TTM 3.56b - Cost of Revenue TTM 2.33b) / Revenue TTM)
Gross Margin QoQ = 35.16% (prev 35.11%)
Tobins Q-Ratio = 1.77 (Enterprise Value 4.68b / Total Assets 2.64b)
Interest Expense / Debt = 1.79% (Interest Expense 2.00m / Debt 112.0m)
Taxrate = 26.96% (31.0m / 115.0m)
NOPAT = 314.1m (EBIT 430.0m * (1 - 26.96%))
Current Ratio = 2.19 (Total Current Assets 1.36b / Total Current Liabilities 621.0m)
Debt / Equity = 0.06 (Debt 112.0m / totalStockholderEquity, last quarter 1.89b)
Debt / EBITDA = -0.27 (Net Debt -142.0m / EBITDA 530.0m)
Debt / FCF = -0.44 (Net Debt -142.0m / FCF TTM 326.0m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.27% (Net Income 295.0m / Total Assets 2.64b)
RoE = 15.61% (Net Income TTM 295.0m / Total Stockholder Equity 1.89b)
RoCE = 22.63% (EBIT 430.0m / Capital Employed (Equity 1.89b + L.T.Debt 10.0m))
RoIC = 16.19% (NOPAT 314.1m / Invested Capital 1.94b)
WACC = 6.77% (E(4.71b)/V(4.82b) * Re(6.90%) + D(112.0m)/V(4.82b) * Rd(1.79%) * (1-Tc(0.27)))
Discount Rate = 6.90% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -0.78%
[DCF Debug] Terminal Value 85.06% ; FCFF base≈326.8m ; Y1≈391.7m ; Y5≈624.4m
Fair Price DCF = 216.9 (EV 14.07b - Net Debt -142.0m = Equity 14.21b / Shares 65.5m; r=6.77% [WACC]; 5y FCF grow 21.21% → 2.90% )
EPS Correlation: -15.32 | EPS CAGR: -46.21% | SUE: -4.0 | # QB: 0
Revenue Correlation: 57.02 | Revenue CAGR: 5.16% | SUE: 0.01 | # QB: 0
EPS next Year (2026-12-31): EPS=2.45 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+6.9% | Growth Revenue=+2.4%